MOSAIC BIOMEDICALS
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system.
MOSAIC BIOMEDICALS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2013-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.mosaicbiomedicals.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Apache 2.4 Debian CDMon
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Chamelic
Chamelic is a chemistry technology company developing an anti-fog surface treatment.
MetaboStem
MetaboStem is a Biotechnology company developing breakthrough oncology drugs
Current Advisors List
Official Site Inspections
http://www.mosaicbiomedicals.com
- Host name: vxhca-35.srv.cat
- IP address: 134.0.14.238
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Mosaic Biomedicals"
Mosaic Biomedicals - Crunchbase Company Profile & Funding
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s …See details»
Mosaic | VHIR - Vall d'Hebron Institut de Recerca
Mosaic Biomedicals is a company founded in 2013 with the aim of developing personalized treatments for cancer with a dual action mechanism that eliminates cancer stem cells and reactivates the tumor's immune system.See details»
Mosaic Biomedicals - VentureRadar
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s …See details»
Mosaic Biomedicals accelerates clinical trials of first-in- class ...
Mosaic Biomedicals SL today announced a merger with Northern Biologics Inc. that will enable the accelerated development of MSC-1, a humanized antibody expected to begin clinical trials …See details»
Mosaic Biomedicals Company Profile 2024: Valuation, Investors ...
Provider of cancer treatment services intended for cancer patients. The company is engaged in developing personalized cancer treatments with a dual mechanism of action to eliminate …See details»
Mosaic Biomedicals - Overview, News & Similar companies
Who is Mosaic Biomedicals. Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer st em …See details»
Mosaic Biomedicals Company Profile | Management and
Mosaic Biomedicals Profile and History. Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer …See details»
Mosaic Biomedicals - Products, Competitors, Financials, Employees ...
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor's …See details»
Mosaic Biomedicals SL - Company Profile and News
Mosaic Biomedicals SL operates as a biotechnology company. The Company develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells …See details»
Mosaic Biomedicals merges with Canadian firm Northern Biologics
The compound Mosaic Biomedicals is developing is a first-in-class antibody for LIF, a pleiotropic cytokine that is overexpressed in certain solid tumors. LIF promotes cancer progression by …See details»
Northern Biologics, Mosaic Biomedicals Execute ... - Newswire
Dec 19, 2016 · Mosaic Biomedicals is a Barcelona -based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and …See details»
Mosaic Biomedicals acquired by Northern Biologics Inc.
Acquiring Organization: Northern Biologics Inc. Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Announced Date …See details»
Northern Biologics, Mosaic Biomedicals Execute Transformative Deal
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s …See details»
Mosaic Biomedicals - Contacts, Employees, Board Members
Mosaic Biomedicals was a Catalan biotechnology company developing humanised antibodies for the use in oncology.See details»
Mosaic Biomedicals announces a transformative deal that
Dec 19, 2016 · We are exited to announce a transformative deal with Celgene and Northern Biologics that accelerates clinical trials of our first-in-class therapeutic antibody for cancer …See details»
Mosaic Biomedicals se fusiona con la canadiense Northern Biologics
Jan 13, 2017 · La biotecnológica catalana Mosaic Biomedicals, spin-off del Vall d'Hebron Instituto de Oncología fundada por los doctores Joan Seoane, Judit Anido y Josep Baselga, ha …See details»
Northern Biologics - Versant Ventures
In December 2016, the Versant team enabled Northern Biologics to execute a transformative deal with a European biotech, Mosaic Biomedicals, to expand its portfolio through the acquisition of …See details»
Northern Biologics Announces Global Acquisition of Clinical-Stage ...
Nov 10, 2020 · Northern Biologics has reached an agreement for the acquisition of the company’s lead asset, MSC-1, by an AstraZeneca subsidiary. MSC-1 is an anti-LIF antibody that has …See details»
Northern Biologics merges with Mosaic Bio as Versant, Celgene …
Dec 19, 2016 · Canadian biotech Northern Biologics has signed a “transformative” merger deal with Spain’s Mosaic Biomedicals as the new player looks to become a global cancer company, …See details»
Mosaic merger brings Northern Biologics back to LIF(E)
Dec 20, 2016 · DUBLIN – Northern Biologics Inc. is merging with Spanish firm Mosaic Biomedicals SL and at the same time has lined up Celgene Corp. with an option to take …See details»